Aurobindo launches Brivaracetam Tablets
Brivaracetam Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Brivaracetam Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.